Table 1.
Total | Blotting index (case no, %) | |||
---|---|---|---|---|
<0.25 | 0.25-0.5 | >0.5 | ||
Normal | 28 | 28(100%) | – | – |
CCA | 42 | 9(21.43%) | 16(38.09%) | 17(40.48%) |
Clinical stage | ||||
Stage I | 8 | – | 7(88.89%) | 1(11.11%) |
Stage II~IV | 34 | 9(26.47%) | 9(26.47%) | 16(47.06%) |
Tumor location | ||||
EHCC | 31 | 6(19.35%) | 10(32.26%) | 15(48.39%) |
IHCC | 11 | 3(27.27%) | 6(54.55%) | 2(10.18%) |
Sex | ||||
Male | 29 | 7(24.14%) | 12(41.38%) | 10(34.48%) |
Female | 13 | 2(15.39%) | 4(30.77%) | 7(53.84%) |
Age | ||||
40~50 | 1 | – | – | 1(100%) |
50~60 | 6 | 2(33.33%) | 2(33.33%) | 2(33.33%) |
60~70 | 13 | 4(30.77%) | 7(53.85%) | 2(15.38%) |
70~80 | 20 | 3(15%) | 6(30%) | 11(55%) |
80~90 | 2 | – | 1(50%) | 1(50%) |
CCA, cholangiocarcinoma; EHCC, extrahepatic cholangiocarcinoma; IHCC, intrahepatic cholangiocarcinoma.